Variant report
Variant | nsv945870 |
---|---|
Chromosome Location | chr1:73103714-73109803 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs556725997 | chr1:73103715-73103716 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs10889968 | chr1:73103734-73103735 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs537849906 | chr1:73103735-73103736 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs545122151 | chr1:73103781-73103782 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs151166970 | chr1:73103785-73103786 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs77333787 | chr1:73103822-73103823 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs371458837 | chr1:73103832-73103833 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs371998871 | chr1:73103834-73103835 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs546123265 | chr1:73103841-73103842 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs553129393 | chr1:73103855-73103856 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs141239501 | chr1:73103863-73103864 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs541950891 | chr1:73103866-73103867 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs562223279 | chr1:73103867-73103868 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs4650145 | chr1:73103939-73103940 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
15 | rs544617786 | chr1:73103945-73103946 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs57409797 | chr1:73103962-73103963 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs397758520 | chr1:73103968-73103969 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs146919322 | chr1:73104020-73104021 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs11209993 | chr1:73104061-73104062 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs546960394 | chr1:73104096-73104097 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs566658779 | chr1:73104138-73104139 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs531641300 | chr1:73104143-73104144 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs147568894 | chr1:73104147-73104148 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs12024784 | chr1:73104160-73104161 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
25 | rs553709423 | chr1:73104213-73104214 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs537408323 | chr1:73104257-73104258 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs567464420 | chr1:73104278-73104279 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs186422704 | chr1:73104311-73104312 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs570939475 | chr1:73104345-73104346 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs539740809 | chr1:73104350-73104351 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs553292977 | chr1:73104399-73104400 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs573318916 | chr1:73104403-73104404 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs191317312 | chr1:73104411-73104412 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs536015219 | chr1:73104438-73104439 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs180716067 | chr1:73104492-73104493 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs142239491 | chr1:73104534-73104535 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs150163408 | chr1:73104537-73104538 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs564467409 | chr1:73104548-73104549 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs578098633 | chr1:73104550-73104551 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs12028336 | chr1:73104661-73104662 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs10889969 | chr1:73104714-73104715 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs529049007 | chr1:73104740-73104741 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs185156818 | chr1:73104798-73104799 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Melanoma | 17363583 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Rett syndrome | 21593744 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16608533 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 17133270 | CNVD |
Type 2 diabetes | 21956041 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
abnormal development | 18461090 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Poland''s syndrome | 22110015 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Cancer | 22429812 | CNVD |
Effusion lymphoma | 18079361 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cancer | 20164920 | CNVD |
small cell lung cancer | 20016488 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:73100200-73104200 | Enhancers | Cortex derived primary cultured neurospheres | brain |
2 | chr1:73102400-73104000 | Enhancers | H1 Cell Line | embryonic stem cell |
3 | chr1:73102600-73104000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr1:73102600-73104400 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
5 | chr1:73103000-73104000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
6 | chr1:73103000-73104200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
7 | chr1:73103000-73104400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
8 | chr1:73103200-73103800 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
9 | chr1:73103200-73104000 | Enhancers | Brain Germinal Matrix | brain |
10 | chr1:73103400-73104000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
11 | chr1:73103400-73104000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
12 | chr1:73103600-73104200 | Flanking Active TSS | Ganglion Eminence derived primary cultured neurospheres | brain |
13 | chr1:73104000-73104400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
14 | chr1:73104200-73104800 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |